[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lucid Diagnostics Inc (LUCD)

Lucid Diagnostics Inc (LUCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 232,201
  • Shares Outstanding, K 177,253
  • Annual Sales, $ 4,710 K
  • Annual Income, $ -58,010 K
  • EBIT $ -49 M
  • EBITDA $ -48 M
  • 60-Month Beta 1.24
  • Price/Sales 48.21
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.06
  • Number of Estimates 1
  • High Estimate $-0.06
  • Low Estimate $-0.06
  • Prior Year $-0.17
  • Growth Rate Est. (year over year) +64.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0900 unch
on 04/23/26
1.4444 -24.54%
on 04/16/26
-0.1600 (-12.80%)
since 03/23/26
3-Month
1.0900 unch
on 04/23/26
1.5000 -27.33%
on 02/25/26
-0.1200 (-9.92%)
since 01/23/26
52-Week
0.9495 +14.80%
on 08/01/25
1.7000 -35.88%
on 05/27/25
-0.2000 (-15.50%)
since 04/23/25

Most Recent Stories

More News
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock

NEW YORK , April 23, 2026 /PRNewswire/ -- Lucid Diagnostics Inc.  (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary...

LUCD : 1.0900 (-16.79%)
PAVM : 9.17 (-2.13%)
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference

NEW YORK , April 9, 2026 /PRNewswire/ --  Lucid Diagnostics Inc.   (Nasdaq: LUCD)  ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company...

LUCD : 1.0900 (-16.79%)
PAVM : 9.17 (-2.13%)
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio

Medtech industry veteran to oversee development and commercialization of PAVmed's current and future medical device portfolio.

LUCD : 1.0900 (-16.79%)
PAVM : 9.17 (-2.13%)
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

PAVmed strengthened its capital structure and relaunched its medical device portfolio under new leadership

LUCD : 1.0900 (-16.79%)
PAVM : 9.17 (-2.13%)
Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Processed 3,664 EsoGuard ® tests and recognized 4Q25 revenue of $1.5 million

LUCD : 1.0900 (-16.79%)
PAVM : 9.17 (-2.13%)
Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026

Conference Call and Webcast at 8:30 AM ET

LUCD : 1.0900 (-16.79%)
PAVM : 9.17 (-2.13%)
PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities

Series D Preferred Stock offering yielded $30 million of gross proceeds and includes warrants exercisable for up to an additional $30 million upon publication of a positive draft EsoGuard Medicare local...

LUCD : 1.0900 (-16.79%)
PAVM : 9.17 (-2.13%)
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®

NEW YORK , Jan. 21, 2026 /PRNewswire/ -- Lucid Diagnostics Inc.  (Nasdaq: LUCD)  ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics...

LUCD : 1.0900 (-16.79%)
PAVM : 9.17 (-2.13%)
PAVmed Announces Reverse Stock Split

NEW YORK , Dec. 30, 2025 /PRNewswire/ --  PAVmed Inc.  (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical...

LUCD : 1.0900 (-16.79%)
PAVM : 9.17 (-2.13%)
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection

Report includes nearly 12,000 patients who underwent Lucid's EsoGuard ® Esophageal DNA Test on samples collected using its EsoCheck ® Esophageal Cell Collection Device

LUCD : 1.0900 (-16.79%)
PAVM : 9.17 (-2.13%)

Business Summary

Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. Lucid Diagnostics Inc. is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 1.2567
2nd Resistance Point 1.2233
1st Resistance Point 1.1567
Last Price 1.0900
1st Support Level 1.0567
2nd Support Level 1.0233
3rd Support Level 0.9567

See More

52-Week High 1.7000
Fibonacci 61.8% 1.4133
Fibonacci 50% 1.3248
Fibonacci 38.2% 1.2362
Last Price 1.0900
52-Week Low 0.9495

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.